433 related articles for article (PubMed ID: 27541645)
1. NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach.
Svennberg E; Lindahl B; Berglund L; Eggers KM; Venge P; Zethelius B; Rosenqvist M; Lind L; Hijazi Z
Int J Cardiol; 2016 Nov; 223():74-81. PubMed ID: 27541645
[TBL] [Abstract][Full Text] [Related]
2. Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study.
Xiao J; Persson AP; Engström G; Johnson LSB
BMC Cardiovasc Disord; 2021 Mar; 21(1):134. PubMed ID: 33711943
[TBL] [Abstract][Full Text] [Related]
3. Discovery of new biomarkers for atrial fibrillation using a custom-made proteomics chip.
Lind L; Sundström J; Stenemo M; Hagström E; Ärnlöv J
Heart; 2017 Mar; 103(5):377-382. PubMed ID: 27609943
[TBL] [Abstract][Full Text] [Related]
4. Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation.
Staszewsky L; Meessen JMTA; Novelli D; Wienhues-Thelen UH; Disertori M; Maggioni AP; Masson S; Tognoni G; Franzosi MG; Lucci D; Latini R
BMC Cardiovasc Disord; 2021 Nov; 21(1):553. PubMed ID: 34798808
[TBL] [Abstract][Full Text] [Related]
5. Exploration of pathophysiological pathways for incident atrial fibrillation using a multiplex proteomic chip.
Molvin J; Jujic A; Melander O; Pareek M; Råstam L; Lindblad U; Daka B; Leosdottir M; Nilsson P; Olsen M; Magnusson M
Open Heart; 2020; 7(1):e001190. PubMed ID: 32201587
[TBL] [Abstract][Full Text] [Related]
6. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
Skoglund PH; Arpegård J; Ostergren J; Svensson P
Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
[TBL] [Abstract][Full Text] [Related]
7. N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation.
Svennberg E; Henriksson P; Engdahl J; Hijazi Z; Al-Khalili F; Friberg L; Frykman V
Heart; 2017 Aug; 103(16):1271-1277. PubMed ID: 28255099
[TBL] [Abstract][Full Text] [Related]
8. Association of N-terminal pro B-type natriuretic peptide (NT-proBNP) change with the risk of atrial fibrillation in the ARIC cohort.
Li L; Selvin E; Lutsey PL; Hoogeveen RC; O'Neal WT; Soliman EZ; Chen LY; Alonso A
Am Heart J; 2018 Oct; 204():119-127. PubMed ID: 30099337
[TBL] [Abstract][Full Text] [Related]
9. Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation.
Smith JG; Newton-Cheh C; Almgren P; Struck J; Morgenthaler NG; Bergmann A; Platonov PG; Hedblad B; Engström G; Wang TJ; Melander O
J Am Coll Cardiol; 2010 Nov; 56(21):1712-9. PubMed ID: 21070922
[TBL] [Abstract][Full Text] [Related]
10. Joint Associations of Obesity and NT-proBNP With the Incidence of Atrial Fibrillation in the ARIC Study.
Almuwaqqat Z; O'Neal WT; Norby FL; Lutsey PL; Selvin E; Soliman EZ; Chen LY; Alonso A
J Am Heart Assoc; 2019 Oct; 8(19):e013294. PubMed ID: 31564186
[TBL] [Abstract][Full Text] [Related]
11. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Christersson C; Ezekowitz J; Gersh BJ; Hanna M; Hohnloser S; Horowitz J; Huber K; Hylek EM; Lopes RD; McMurray JJ; Granger CB
J Am Coll Cardiol; 2013 Jun; 61(22):2274-84. PubMed ID: 23563134
[TBL] [Abstract][Full Text] [Related]
12. Atrial ectopy and N-terminal pro-B-type natriuretic peptide as predictors of atrial fibrillation: a population-based cohort study.
Kumarathurai P; Mouridsen MR; Mattsson N; Larsen BS; Nielsen OW; Gerds TA; Sajadieh A
Europace; 2017 Mar; 19(3):364-370. PubMed ID: 27194537
[TBL] [Abstract][Full Text] [Related]
13. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
Pareek M; Bhatt DL; Vaduganathan M; Biering-Sørensen T; Qamar A; Diederichsen AC; Møller JE; Hindersson P; Leósdóttir M; Magnusson M; Nilsson PM; Olsen MH
Eur J Prev Cardiol; 2017 Oct; 24(15):1648-1659. PubMed ID: 28644092
[TBL] [Abstract][Full Text] [Related]
14. N-terminal pro-B-type natriuretic peptide as a predictor of incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis: the effects of age, sex and ethnicity.
Patton KK; Heckbert SR; Alonso A; Bahrami H; Lima JA; Burke G; Kronmal RA
Heart; 2013 Dec; 99(24):1832-6. PubMed ID: 24131775
[TBL] [Abstract][Full Text] [Related]
15. Elevated admission N-terminal pro-brain natriuretic peptide level predicts the development of atrial fibrillation in general surgical intensive care unit patients.
Chokengarmwong N; Yeh DD; Chang Y; Ortiz LA; Kaafarani HMA; Fagenholz P; King DR; DeMoya M; Butler K; Lee J; Velmahos G; Januzzi JL; Lee-Lewandrowski E; Lewandrowski K
J Trauma Acute Care Surg; 2017 Sep; 83(3):485-490. PubMed ID: 28463935
[TBL] [Abstract][Full Text] [Related]
16. Amino-terminal B-natriuretic peptide levels and postablation recurrence in hypertensive patients with paroxysmal atrial fibrillation.
Giannopoulos G; Kossyvakis C; Angelidis C; Efremidis M; Panagopoulou V; Letsas K; Bouras G; Vassilikos VP; Goudevenos J; Tousoulis D; Lekakis J; Deftereos S
Heart Rhythm; 2015 Jul; 12(7):1470-5. PubMed ID: 25847478
[TBL] [Abstract][Full Text] [Related]
17. Exploring the incremental utility of circulating biomarkers for robust risk prediction of incident atrial fibrillation in European cohorts using regressions and modern machine learning methods.
Toprak B; Brandt S; Brederecke J; Gianfagna F; Vishram-Nielsen JKK; Ojeda FM; Costanzo S; Börschel CS; Söderberg S; Katsoularis I; Camen S; Vartiainen E; Donati MB; Kontto J; Bobak M; Mathiesen EB; Linneberg A; Koenig W; Løchen ML; Di Castelnuovo A; Blankenberg S; de Gaetano G; Kuulasmaa K; Salomaa V; Iacoviello L; Niiranen T; Zeller T; Schnabel RB
Europace; 2023 Mar; 25(3):812-819. PubMed ID: 36610061
[TBL] [Abstract][Full Text] [Related]
18. SERUM cardiac-specific biomarkers and atrial fibrillation in myotonic dystrophy type I.
Russo V; Rago A; Atripaldi L; Leonardi S; Papa AA; Politano L; Golino P; Potpara TS; Nigro G
J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2914-2919. PubMed ID: 31579995
[TBL] [Abstract][Full Text] [Related]
19. N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study.
Patton KK; Ellinor PT; Heckbert SR; Christenson RH; DeFilippi C; Gottdiener JS; Kronmal RA
Circulation; 2009 Nov; 120(18):1768-74. PubMed ID: 19841297
[TBL] [Abstract][Full Text] [Related]
20. Association of NT-proBNP and GDF-15 with markers of a prothrombotic state in patients with atrial fibrillation off anticoagulation.
Matusik PT; Małecka B; Lelakowski J; Undas A
Clin Res Cardiol; 2020 Apr; 109(4):426-434. PubMed ID: 31280356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
